GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ace (ACE) [hlAlert]

Rating:
Outperform
ACE
up 88.71 %

Ace (ACE) rated Outperform with price target $109 by RBC Capital Mkts

Posted on: Thursday,  Jan 30, 2014  9:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Ace (NYSE: ACE) on 01/30/2014. Previously RBC Capital Mkts rated Outperform Ace (NYSE: ACE) on 10/21/2009.,
when the stock price was $54.92. Since then, Ace has gained 88.71% as of 01/05/2016's recent price of $103.64.
If you would have followed the previous RBC Capital Mkts's recommendation on ACE, you would have gained 88.71% of your investment in 2267 days.

Alcon, Inc. is the world's leading eye care company. Alcon, which has been dedicated to the ophthalmic industry for sixty years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon's majority shareholder is Nestle, S.A., the world's largest food company. All trademarks noted in this release are the property of Alcon, Inc., with the exception of Ciprodex, which is a registered trademark of Bayer AG and licensed to Alcon, Inc. by Bayer Healthcare AG. Moxifloxacin is licensed to Alcon, Inc. by Bayer Healthcare AG.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/30/2014 9:25 AM Buy
None
95.14 109.00
as of 10/17/2014
1 Week down  -0.27 %
1 Month down  -1.32 %
3 Months up  1.26 %
1 YTD up  1.04 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/25/2012 10:25 AM Buy
None
80.01 91.00
7/28/2011 9:25 AM Buy
None
68.50 78.00
2/4/2011 8:25 AM Buy
None
63.06 73.00
10/29/2010 9:25 AM Buy
None
59.59 71.00
10/21/2009 8:25 AM Buy
None
54.92

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy